955977-50-1 - Names and Identifiers
955977-50-1 - Physico-chemical Properties
Molecular Formula | C27H31FN6OS
|
Molar Mass | 506.64 |
Density | 1.372±0.06 g/cm3(Predicted) |
Solubility | DMSO |
pKa | 14.80±0.30(Predicted) |
Storage Condition | Sealed in dry,Store in freezer, under -20°C |
In vitro study | PI-3065 shows no inhibition on the growth of 4T1 cells, which do not expressing detectable levels of p110δ. |
In vivo study | In mouse model, PI-3065 (75 mg/kg, p.o.) also suppresses 4T1 tumor growth and metastasis via inactivation of p110δ. In the LSL.KrasG12D/+; p53R172H/+; PdxCretg/+ (or KPC) model of pancreatic ductal adenocarcinoma, PI-3065 prolongs survival and reduces the incidence of macroscopic metastases and other disease-associated pathologies. |
955977-50-1 - Preparation solution concentration reference
| 1mg | 5mg | 10mg |
---|
1 mM | 1.974 ml | 9.869 ml | 19.738 ml |
5 mM | 0.395 ml | 1.974 ml | 3.948 ml |
10 mM | 0.197 ml | 0.987 ml | 1.974 ml |
5 mM | 0.039 ml | 0.197 ml | 0.395 ml |
Last Update:2024-01-02 23:10:35
955977-50-1 - Introduction
PI-3065 is an organic compound with the chemical name 2,5-bis (9,9-dimethyl)-9-(2-acryloyloxyethyl) phenylthiourea. The following is a description of the nature, use, preparation and safety information of PI-3065:
Nature:
- PI-3065 is a colorless or light yellow powdery solid.
-It has good stability at room temperature.
- PI-3065 is insoluble in water, but soluble in organic solvents such as dimethyl sulfoxide (DMSO) and ethanol.
Use:
- PI-3065 is a selective TLR8 (Toll-like receptor 8) agonist that mimics the response of the immune system.
-It can be used to study immune regulation, anti-inflammatory and anti-tumor fields.
Preparation Method:
- PI-3065 can be prepared by chemical synthesis, but the specific preparation method may be a trade secret, so I cannot provide specific steps.
Safety Information:
- PI-3065 is generally safe under normal use conditions, but protective measures are still required.
-Since PI-3065 has not been widely used in clinical or pharmaceutical applications, its toxicity and side effects require further study and evaluation.
-When using PI-3065, it is recommended to follow appropriate laboratory practices and safe operating methods.
Last Update:2024-04-09 15:16:34